Paper29201665
The Effect of Curcumin on TNF-α, IL-6 and CRP Expression in a Model of Polycystic Ovary Syndrome as an Inflammation State.
Mohammadi S and 3 others. J Reprod Infertil, 2017. Cited by 77 papers, by iCite.
Cite this record
ConductScience Library. The Effect of Curcumin on TNF-α, IL-6 and CRP Expression in a Model of Polycystic Ovary Syndrome as an Inflammation State. Papers, record 29201665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29201665
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Effect of Curcumin on TNF-α, IL-6 and CRP Expression in a Model of Polycystic Ovary Syndrome as an Inflammation State.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23119079 | Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation. | PLoS One | 2012 | https://conductscience.org/library/papers/23119079 | PubMed |
| 2 | 23890132 | Effects of curcumin on proinflammatory cytokines and tissue injury in the early and late phases of experimental acute pancreatitis. | Pancreatology | 2013 | https://conductscience.org/library/papers/23890132 | PubMed |
| 3 | 11980740 | 'Early coasting' in patients with polycystic ovarian syndrome is consistent with good clinical outcome. | Hum Reprod | 2002 | https://conductscience.org/library/papers/11980740 | PubMed |
| 4 | 17569205 | Curcumin: the Indian solid gold. | Adv Exp Med Biol | 2007 | https://conductscience.org/library/papers/17569205 | PubMed |
| 5 | 18450960 | Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. | Endocrinology | 2008 | https://conductscience.org/library/papers/18450960 | PubMed |
| 6 | 16413584 | Multiple biological activities of curcumin: a short review. | Life Sci | 2006 | https://conductscience.org/library/papers/16413584 | PubMed |
| 7 | 15604534 | Expression of cytoskeletal proteins in the follicular wall of induced ovarian cysts. | Cells Tissues Organs | 2004 | https://conductscience.org/library/papers/15604534 | PubMed |
| 8 | 19726538 | Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. | Endocr Relat Cancer | 2009 | https://conductscience.org/library/papers/19726538 | PubMed |
| 9 | 25096410 | Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review. | BMC Womens Health | 2014 | https://conductscience.org/library/papers/25096410 | PubMed |
| 10 | 21642934 | Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. | Molecules | 2011 | https://conductscience.org/library/papers/21642934 | PubMed |
| 11 | 12798883 | Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. | Fertil Steril | 2003 | https://conductscience.org/library/papers/12798883 | PubMed |
| 12 | 14551013 | Quantification of ovarian power Doppler signal with three-dimensional ultrasonography to predict response during in vitro fertilization. | Obstet Gynecol | 2003 | https://conductscience.org/library/papers/14551013 | PubMed |
| 13 | 21547256 | IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance. | Mediators Inflamm | 2011 | https://conductscience.org/library/papers/21547256 | PubMed |
| 14 | 23200686 | Letrozole increases ovarian growth and Cyp17a1 gene expression in the rat ovary. | Fertil Steril | 2013 | https://conductscience.org/library/papers/23200686 | PubMed |
| 15 | 17214387 | The role of metformin in the treatment of polycystic ovary syndrome (PCOS). | Chang Gung Med J | 2006 | https://conductscience.org/library/papers/17214387 | PubMed |
| 16 | 10880413 | Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). | Circulation | 2000 | https://conductscience.org/library/papers/10880413 | PubMed |
| 17 | 18629352 | Androgen therapy and atherosclerotic cardiovascular disease. | Vasc Health Risk Manag | 2008 | https://conductscience.org/library/papers/18629352 | PubMed |
| 18 | 18406243 | Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. | Trends Endocrinol Metab | 1998 | https://conductscience.org/library/papers/18406243 | PubMed |
| 19 | 15531516 | Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. | J Clin Endocrinol Metab | 2004 | https://conductscience.org/library/papers/15531516 | PubMed |
| 20 | 12871882 | Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours. | Hum Reprod | 2003 | https://conductscience.org/library/papers/12871882 | PubMed |
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42539648 | Genistein in polycystic ovary syndrome: mechanisms, preclinical evidence, and translational potential. | Front Glob Womens Health | 2026 | https://conductscience.org/library/papers/42539648 | PubMed |
| 42481844 | Bioactive Natural Compounds: A Review of Their Integration into Bone Tissue Engineering Scaffolds. | Ann Biomed Eng | 2026 | https://conductscience.org/library/papers/42481844 | PubMed |
| 41797792 | From bench to bedside: unlocking the anti-inflammatory, antioxidant, and anticancer promise of curcumin in gynecology. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41797792 | PubMed |
| 41784928 | Therapeutic efficacy of Curcuma longa leaf extract in experimental models of arthritis. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/41784928 | PubMed |
| 41680525 | Date palm pollen extract improves fertility and pregnancy outcomes in letrozole-induced polycystic ovary syndrome rats. | J Mol Histol | 2026 | https://conductscience.org/library/papers/41680525 | PubMed |
| 41630761 | Blumea balsamifera (L.) DC. and Sargassum aquifolium J. Agardh extracts as anti-atherosclerotic, anti-inflammatory, and hepatoprotective agents in Wistar rats induced by a high-cholesterol diet. | Open Vet J | 2025 | https://conductscience.org/library/papers/41630761 | PubMed |
| 41549177 | Therapeutic potential of 7-hydroxyflavone in letrozole-induced polycystic ovarian syndrome via regulation of oxidative stress, inflammation, hormonal and biochemical dysregulation. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41549177 | PubMed |
| 41155686 | Targeting Polycystic Ovary Syndrome (PCOS) Pathophysiology with Flavonoids: From Adipokine-Cytokine Crosstalk to Insulin Resistance and Reproductive Dysfunctions. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155686 | PubMed |
| 41104232 | IDO Inhibition by 1-Methyltryptophan: Unlocking New Paths to Treat Ovarian Dysfunction and Hormonal Imbalance in PCOS. | Iran J Pharm Res | 2025 | https://conductscience.org/library/papers/41104232 | PubMed |
| 40947705 | Unraveling the Complexity of Polycystic Ovary Syndrome: Biomarkers for Diagnosis, Prognosis, and Treatment. | Curr Pharm Des | 2026 | https://conductscience.org/library/papers/40947705 | PubMed |
| 40783741 | Comparative advantage and efficacy of natural products for polycystic ovary syndrome. | J Ovarian Res | 2025 | https://conductscience.org/library/papers/40783741 | PubMed |
| 40393653 | New insights into pentoxifylline and α-lipoic acid: Co-administration with clomiphene citrate for ovulation induction in anovulatory women with polycystic ovary syndrome. | Clin Exp Reprod Med | 2026 | https://conductscience.org/library/papers/40393653 | PubMed |
| 39683427 | Biomarker-Guided Dietary Supplementation: A Narrative Review of Precision in Personalized Nutrition. | Nutrients | 2024 | https://conductscience.org/library/papers/39683427 | PubMed |
| 39634175 | The therapeutic effects of curcumin on polycystic ovary syndrome by upregulating PPAR-γ expression and reducing oxidative stress in a rat model. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39634175 | PubMed |
| 39617843 | Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability. | Sci Rep | 2024 | https://conductscience.org/library/papers/39617843 | PubMed |
| 39421997 | Beneficial Effects of Curcumin in Polycystic Ovary Syndrome: A Review of Recent Literature and Underlying Mechanisms. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39421997 | PubMed |
| 39247793 | Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39247793 | PubMed |
| 39219692 | Mechanism of YJKL Decoction in Treating of PCOS Infertility by Integrative Approach of Network Pharmacology and Experimental Verification. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39219692 | PubMed |
| 38509545 | A matter of new life and cell death: programmed cell death in the mammalian ovary. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/38509545 | PubMed |
| 38139406 | Copper in Gynecological Diseases. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38139406 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| IL18 | 3606 | PubTator's text mining | https://conductscience.org/library/genes/3606 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29201665
GET https://conductscience.org/api/papers/v1/29201665/references?page=2